Management of Indralupta (Alopecia Areata) with Prachchhana Karma and Bibhitaka Lepa—An Open Labelled Single Arm Clinical Trial

Authors

  • Shital K. Baraiya Assistant Professor, Department of Shalakya Tantra, Netra Chikitsa Trust Ayurveda College, Amreli, Gujarat, India
  • Bhakti Chhaya Associate Professor, Department of Shalakya Tantra, Govt. Akhandanand Ayurved College, Ahmedabad, Gujarat, India
  • Mehul Gohil community health officer, Department of Ayurveda, Medicine and Surgery, Community Health Officer at Morba Health Centre, Gariyadhar, Gujarat, India
  • Khyati Bhupta Assistant Professor, Department of Shalakya Tantra, Eva College of Ayurveda, Supedi, Gujarat, India
  • Sejal Gamit Assistant Professor, Department of Shalakya Tantra, Sumandeep Ayurved College, Vadodara, Gujarat, India

Keywords:

Shiro Roga, Indralupta, Prachchhana, Bibhitaka Lepa, Keshya

Abstract

There are eight branches of Ayurveda, Shalakya Tantra is one of them. Acharya Sushruta has mentioned 11 types of Shiro Roga and Acharya Vagbhatta described 10 types of Shiro Roga; he also described nine types of Shirokapalgata Roga. In Ayurvedic approach, loss of hair is coined out as in term of ‘Indralupta’ under the broad heading of Kshudra Roga except Vagabhatta who has mentioned it under Kapala Roga. According to Acharya Sushruta and Vagbhatta, Vata Doṣha along with Pitta Doṣha resides in Romkoopa (hair root) results in hair fall (Keshapatan). After then Kapha Doṣha along with Rakta Doṣha block Romkoopa (hair root) so no more hair produce on that place, it results in Indralupta. Indralupta occurs due to Rakta Dushti and treatment of Indralupta, Prachchhana karma is stated by major Acharyas. Nowadays, many Ayurvedic practitioners use Bibhitakaa Lepa as a Keshya but we need to prove it scientifically so Bibhitaka has been selected in form of Lepa. Bibhitaka is Keshya so keeping in mind the above reference, we selected the treatment Prahcchhana as Shodhan therapy and Lepan as a Shaman therapy. For evidence database both these treatments were selected. Total 32 patients were registered, in which 30 patients continued their therapy. Prachchhana Karma was done in one sitting followed by Bibhitaka Lepa for 21 days. The effect of therapy was assessed by a specially prepared proforma. The data obtained in clinical study were analysed by using Paired ‘t’ test.

Author Biography

  • Shital K. Baraiya, Assistant Professor, Department of Shalakya Tantra, Netra Chikitsa Trust Ayurveda College, Amreli, Gujarat, India
    Department Of Shalakya Tantra, Goverment Akhandanand Ayurveda College,Ahmedabad

References

Shastri KA, Editor. Sushruta Samhita with Ayurveda Tatva Sandipika commentary, 14th ed., Sutrasthan.1/7. Varanasi, India: Chaukhambha Sanskrit Sansthan; 2003. 5p.

Shastri KA, Editor. Sushruta Samhita with Ayurveda Tatva Sandipika commentary, 14th ed., Sutrasthan-1/7(2). Varanasi, India: Chaukhambha Sanskrit Sansthan; 2003. 5p.

Shastri KA, Editor. Sushruta Samhita with Ayurveda Tatva Sandipika commentary, 14th ed., Sutrasthan-1/9. Varanasi, India: Chaukhambha Sanskrit Sansthan, Varanasi; 2003. 5p.

Shastri KA, Editor. Sushruta Samhita with Ayurveda Tatva Sandipika commentary, 14th ed., Uttartantra 25/4. Varanasi, India: Chaukhambha Sanskrit Sansthan; 2003.159p.

Bhisagacarya HSSP, Editor. Ashtanga Hridaya with the commentaries Sarvangasundara of Arundatta and Ayurveda Rasayana of Hemadri, Uttaratantra 23/20. Varanasi, India: Chaukhamba Orientalia; 2010. 1052p.

Bhisagacarya HSSP, Editor. AshtangaHridaya with the commentaries Sarvangasundara of Arundatta and Ayurveda Rasayana of Hemadri, Uttaratantra 23/20(2). Varanasi, India: Chaukhamba Orientalia; 2010. 1053p.

Shastri KA, Editor. Sushruta Samhita with Ayurveda Tatva Sandipika commentary, 14th ed., Nidansthan.-13/32-33. Varanasi, India: Chaukhambha Sanskrit Sansthan; 2003. 368p.

Bhisagacarya HSSP, Editor. AshtangaHridaya with the commentaries Sarvangasundara of Arundatta and Ayurveda Rasayana of Hemadri, Uttaratantra 23/24-25. Varanasi, India: Chaukhamba Orientalia; 2010.1053p.

Shastri KA, Editor. Sushruta Samhita with Ayurveda Tatva Sandipika commentary, 14th ed., Nidansthan.-13/32-33. Varanasi, India: Chaukhambha Sanskrit Sansthan; 2003. 368p.

Acharya VJT. Charaka Samhita - Ayurveda Dipika Commentary of Chakrapanidatta, Chikitshasthana- 15/19. Varanasi, India: Chaukhamba Sanskrit Sansthana; reprint 2009. 456p.

Shastri KA, Editor. Sushruta Samhita with Ayurveda Tatva Sandipika commentary, 14th ed., Sutrasthan.-24/11. Varanasi, India: Chaukhambha Sanskrit Sansthan; 2003. 132p.

Shastri KA, Editor. Sushruta Samhita with Ayurveda Tatva Sandipika commentary, 14th ed., Sutrasthan.-25/15. Varanasi, India: Chaukhambha Sanskrit Sansthan; 2003. 134p.

Shastri KA, Editor. Sushruta Samhita with Ayurveda Tatva Sandipika commentary, 14th ed., Sutrasthan.-14/25. Varanasi, India: Chaukhambha Sanskrit Sansthan; 2003. 70p.

Shastri KA, Editor. Sushruta Samhita with Ayurveda Tatva Sandipika commentary, 14th ed., Chikitsasthan.-20/25. Varanasi, India: Chaukhambha Sanskrit Sansthan; 2003. 117p.

Chunekara KC. Bhvaprakasha Nighantu, Nidansthan-1/37. Varanasi, India: Chaukhmabha Bharati Academy; 2010. 9p.

Downloads

Published

2021-11-01

Issue

Vol. 8 No. 3 (2021)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.